pI: 8.3308 |
Length (AA): 163 |
MW (Da): 18258 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128864)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G36630 | protein EMBRYO DEFECTIVE 2754 |
Brugia malayi | Bm1_00995 | hypothetical protein |
Candida albicans | CaO19.1568 | similar to C terminus of S. cerevisiae Rab guanyl-nucleotide exchange factor VAM6 (YDL077C) involved in vacuolar morphogenesis |
Candida albicans | CaO19.9141 | similar to C terminus of S. cerevisiae Rab guanyl-nucleotide exchange factor VAM6 (YDL077C) involved in vacuolar morphogenesis |
Candida albicans | CaO19.1567 | similar to N terminus of S. pombe VAM6-like putative vacuolar protein vps39 (SPAC23H4.14) |
Candida albicans | CaO19.9140 | similar to N terminus of S. pombe VAM6-like putative vacuolar protein vps39 (SPAC23H4.14) |
Caenorhabditis elegans | CELE_T08G5.5 | Protein VPS-39, isoform C |
Dictyostelium discoideum | DDB_G0279169 | citron-like domain-containing protein |
Drosophila melanogaster | Dmel_CG7146 | Vacuolar protein sorting 39 |
Echinococcus granulosus | EgrG_001200800 | Vam6:Vps39 protein |
Echinococcus multilocularis | EmuJ_001200800 | Vam6:Vps39 protein |
Homo sapiens | ENSG00000166887 | vacuolar protein sorting 39 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.20.6010 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_120910.1 | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative |
Leishmania infantum | LinJ.12.0910 | hypothetical protein, conserved |
Leishmania major | LmjF.12.1320 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.12.1320 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_10497 | hypothetical protein |
Loa Loa (eye worm) | LOAG_11035 | hypothetical protein |
Mus musculus | ENSMUSG00000027291 | vacuolar protein sorting 39 (yeast) |
Oryza sativa | 4333909 | Os03g0715500 |
Saccharomyces cerevisiae | YDL077C | Vam6p |
Schistosoma japonicum | Sjp_0209840 | expressed protein |
Schistosoma japonicum | Sjp_0116730 | hypothetical protein |
Schistosoma mansoni | Smp_193210 | hypothetical protein |
Schistosoma mansoni | Smp_192990 | hypothetical protein |
Schistosoma mansoni | Smp_188660 | hypothetical protein |
Schistosoma mansoni | Smp_034210 | vam6/vps39 related |
Schmidtea mediterranea | mk4.010238.00 | |
Schmidtea mediterranea | mk4.015131.01 | |
Trypanosoma brucei gambiense | Tbg972.1.3280 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.1.4760 | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative |
Trypanosoma congolense | TcIL3000_1_1970 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.507997.60 | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative |
Trypanosoma cruzi | TcCLB.508593.50 | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative |
Trypanosoma cruzi | TcCLB.508823.90 | hypothetical protein |
Trichomonas vaginalis | TVAG_027270 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.1.4760 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.1.4760 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.1.4760 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.1.4760 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T08G5.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.